Article Information
History
- July 15, 2020.
Article Versions
- Version 1 (June 7, 2020 - 22:13).
- Version 2 (June 10, 2020 - 11:54).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ludovico Cantuti-Castelvetri1,2,*,
- Ravi Ojha3,*,
- Liliana D. Pedro1,2,*,
- Minou Djannatian1,2,*,
- Jonas Franz4,*,
- Suvi Kuivanen5,*,
- Katri Kallio3,
- Tuğberk Kaya1,2,6,
- Maria Anastasina3,7,
- Teemu Smura5,
- Lev Levanov5,
- Leonora Szirovicza5,
- Allan Tobi8,
- Hannimari Kallio-Kokko9,
- Pamela Österlund10,
- Merja Joensuu11,
- Frédéric A. Meunier11,
- Sarah Butcher3,7,
- Martin Sebastian Winkler12,
- Brit Mollenhauer13,
- Ari Helenius14,
- Ozgun Gokce6,19,
- Tambet Teesalu3,15,16,
- Jussi Hepojoki5,17,
- Olli Vapalahti5,9,18,
- Christine Stadelmann4,
- Giuseppe Balistreri3,§ and
- Mikael Simons1,2,19,§
- 1Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany
- 2German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- 3Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland
- 4Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany
- 5University of Helsinki, Medicum, Department of Virology, Helsinki, Finland
- 6Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- 7Helsinki Institute of Life Sciences-Institute of Biotechnology, University of Helsinki, Finland
- 8Laboratory of Cancer Biology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
- 9University of Helsinki and Helsinki University Hospital, Department of Virology, Helsinki, Finland
- 10Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- 11Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
- 12Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany
- 13Department of Neurology, University Medical Center Göttingen, Göttingen, Germany & Paracelsus-Elena-Klinik Kassel, Kassel, Germany
- 14Institute of Biochemistry, ETH Zürich, Zürich, Switzerland
- 15Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA
- 16Center for Nanomedicine and Department of Cell, Molecular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, California, USA
- 17Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland
- 18Dept of Veterinary Biosciences, University of Helsinki, Helsinki, Finland
- 19Munich Cluster of Systems Neurology (SyNergy), Munich, Germany
- ↵§Correspondence: giuseppe.balistreri{at}helsinki.fi & mikael.simons{at}dzne.de
↵* Equal contributions
Posted July 15, 2020.
Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system
